Michael A. Hust

Braunschweig, NI, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 138 publications

The landscape of antibody production systems: recombinant expression for research, diagnostics and therapy.

The landscape of antibody production systems: recombinant expression for research, diagnostics and therapy.

Journal: Frontiers in bioengineering and biotechnology

Published: December 15, 2025

Immunogenic Streptococcus equi cell surface proteins identified by ORFeome phage display.

Immunogenic Streptococcus equi cell surface proteins identified by ORFeome phage display.

Journal: mSphere

Published: November 25, 2025

Resolving the Interference of Anti-CD38 Antibodies on Blood Compatibility Assays Using CD38 "Baitbodies" Approach.

Resolving the Interference of Anti-CD38 Antibodies on Blood Compatibility Assays Using CD38 "Baitbodies" Approach.

Journal: Journal of immunology research

Published: August 05, 2025

Phase I Study Evaluating a Monoclonal Fc-Silenced SARS-CoV-2 Antibody in Patients With Moderate-to-Severe COVID-19.

Phase I Study Evaluating a Monoclonal Fc-Silenced SARS-CoV-2 Antibody in Patients With Moderate-to-Severe COVID-19.

Journal: Clinical therapeutics

Published: June 23, 2025

Phage Display Derived Antibodies Against Antimicrobial Peptide FsPDF2 Reveal Stress Response in European Beech.

Phage Display Derived Antibodies Against Antimicrobial Peptide FsPDF2 Reveal Stress Response in European Beech.

Journal: Plant biotechnology journal

Published: February 12, 2025

Ultrapotent IgA dimeric antibodies neutralize emerging Omicron variants.

Ultrapotent IgA dimeric antibodies neutralize emerging Omicron variants.

Journal: Journal of virology

Published: December 04, 2024

Targeting BCL11B in CAR-engineered lymphoid progenitors drives NK-like cell development with prolonged anti-leukemic activity.

Targeting BCL11B in CAR-engineered lymphoid progenitors drives NK-like cell development with prolonged anti-leukemic activity.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: April 26, 2024

Human antibodies neutralizing the alpha-latrotoxin of the European black widow.

Human antibodies neutralizing the alpha-latrotoxin of the European black widow.

Journal: Frontiers in immunology

Published: March 26, 2024

A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variants.

A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variants.

Journal: Frontiers in immunology

Published: February 06, 2024

Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages.

Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 09, 2024

Neutralisation activity of mucosal IgA against XBB sublineages and BA.2.86.

Neutralisation activity of mucosal IgA against XBB sublineages and BA.2.86.

Journal: The Lancet. Infectious diseases

Published: October 26, 2023

Evaluation of the Neutralizing Antibody STE90-C11 against SARS-CoV-2 Delta Infection and Its Recognition of Other Variants of Concerns.

Evaluation of the Neutralizing Antibody STE90-C11 against SARS-CoV-2 Delta Infection and Its Recognition of Other Variants of Concerns.

Journal: Viruses

Published: September 23, 2023

Showing 1-12 of 138

Last Updated: 09/26/2026